MIT-Spinoff Device Approved by FDA for Essential Tremor

Encora Therapeutics, an MIT-affiliated startup, has secured FDA clearance for its device targeting essential tremor in adults. This development marks a significant step in translating research into medical solutions, initially conceived to aid Parkinson's disease patients. The clearance could improve treatment options for individuals with essential tremor.